patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
teprotumumab
Marketedupdated 2mo agoby Horizon Therapeutics USA Inc
Approvedcommunity read0 votes
all catalysts(8)
approval · 8
Jan 21, 2020
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Oct 26, 2021
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Dec 6, 2022
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Apr 13, 2023
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Jul 17, 2023
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Aug 26, 2025
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Sep 9, 2025
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Nov 24, 2025
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that